You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb43794 |
---|---|
Category | Antibodies |
Description | Mouse Monoclonal to GCPII. |
Clonality | Monoclonal |
Clone Number | GCP-04 |
Tested applications | ICC, IHC-P, WB |
Reactivity | Human, Mouse, Porcine, Rat |
Isotype | Mouse IgG1 |
Immunogen | Recombinant fragment of human GCPII (amino acids 44-750) produced in S2 cells |
Antibody Type | Primary Antibody |
Concentration | 1 mg/ml |
Purity | Purified by protein-A affinity chromatography. |
Conjugation | Unconjugated |
Target | PSMA |
Entrez | 2346 |
UniProt ID | Q04609 |
RRID | AB_10988150 |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Buffer/Preservatives | Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide |
Alternative names | Anti-GCPII antibody Read more... |
Note | For research use only |
Application notes | Western blotting: Recommended dilution: 1 μg/ml; positive control: LNCaP cell line. Sample preparation: Resuspend approx. 50 mil. cells in 1 ml cold lysis buffer (1% NP-40). Incubate 30 min on ice. Mix lysate with non-reducing/reducing Laemmli SDS-PAGE sample buffer. Both reducing and non-reducing conditions. |
Expiration Date | 12 months from date of receipt. |
Immunohistochemistry staining of GCPII in human medulla oblongata by GCP-04 monoclonal antibody. Mag. 40x; positive astrocytes in white matter.
Immunohistochemistry staining of GCPII in human prostate by GCP-04 monoclonal antibody. Mag. 400x; positive epithelium of the prostate glands.
Immunohistochemistry staining of GCPII in porcine kidney by GCP-04 monoclonal antibody. Highly positive proximal glomeruli.
Western blotting analysis of human PSMA using mouse monoclonal antibody GCP-04 on lysates of LNCaP cell line and Jurkat cell line (PSMA non-expressing cell line; negative control) under reducing and non-reducing conditions. Nitrocellulose membrane was probed with 2 µg/ml of mouse anti-PSMA monoclonal antibody followed by IRDye800-conjugated anti-mouse secondary antibody.